Katherine A McDermott1, Keanan J Joyner2, Jahn K Hakes3, Sarah A Okey2, Jesse R Cougle2. 1. Department of Psychology, Florida State University, Tallahassee, FL, USA. Electronic address: mcdermott@psy.fsu.edu. 2. Department of Psychology, Florida State University, Tallahassee, FL, USA. 3. Center for Administrative Records Research and Applications, US Census Bureau, Suitland, MD, USA.
Abstract
BACKGROUND: Pain interference is associated with substance use, but has yet to be considered as a potential indicator of SUDs among substance users. We sought to examine whether moderate and high pain interference would confer risk for SUDs in ever and weekly users. METHODS: Using data from the National Epidemiologic Survey on Alcohol and Related Conditions, logistic regression analyses were conducted to examine the association between pain interference and concurrent and prospective alcohol and nicotine dependence, as well as concurrent cannabis use disorder. Those with no/low pain were used as the reference group. Gender was examined as a moderator. RESULTS: Controlling for relevant covariates, moderate pain interference was associated with past year alcohol (odds ratio [OR] = 1.33, 95% CI, 1.16-1.52, p < .001) and nicotine (OR = 1.41, 95% CI 1.27-1.56, p < .001) dependence among ever users. In prospective analyses, moderate pain interference predicted the development of alcohol (Moderate: OR = 1.56, 95% CI, 1.39-1.75, p < .001) and nicotine (OR = 1.37, 95% CI, 1.14-1.65, p < .001) dependence. Similar results were found with high pain and for weekly users. Both moderate and high pain interference were associated with past-year occurrence of cannabis use disorder for women but not men. High pain predicted the development of nicotine dependence exclusively among males. CONCLUSION: Pain interference may confer risk for the occurrence of cannabis use disorder among female cannabis users and the occurrence and development of alcohol and nicotine dependence among users of both genders. Pain interference may be an important factor to monitor in these populations.
BACKGROUND:Pain interference is associated with substance use, but has yet to be considered as a potential indicator of SUDs among substance users. We sought to examine whether moderate and high pain interference would confer risk for SUDs in ever and weekly users. METHODS: Using data from the National Epidemiologic Survey on Alcohol and Related Conditions, logistic regression analyses were conducted to examine the association between pain interference and concurrent and prospective alcohol and nicotine dependence, as well as concurrent cannabis use disorder. Those with no/low pain were used as the reference group. Gender was examined as a moderator. RESULTS: Controlling for relevant covariates, moderate pain interference was associated with past year alcohol (odds ratio [OR] = 1.33, 95% CI, 1.16-1.52, p < .001) and nicotine (OR = 1.41, 95% CI 1.27-1.56, p < .001) dependence among ever users. In prospective analyses, moderate pain interference predicted the development of alcohol (Moderate: OR = 1.56, 95% CI, 1.39-1.75, p < .001) and nicotine (OR = 1.37, 95% CI, 1.14-1.65, p < .001) dependence. Similar results were found with high pain and for weekly users. Both moderate and high pain interference were associated with past-year occurrence of cannabis use disorder for women but not men. High pain predicted the development of nicotine dependence exclusively among males. CONCLUSION:Pain interference may confer risk for the occurrence of cannabis use disorder among female cannabis users and the occurrence and development of alcohol and nicotine dependence among users of both genders. Pain interference may be an important factor to monitor in these populations.
Authors: Bradley Neddenriep; Deniz Bagdas; Katherine M Contreras; Joseph W Ditre; Jennifer T Wolstenholme; Michael F Miles; M Imad Damaj Journal: Neuropharmacology Date: 2019-09-25 Impact factor: 5.250
Authors: Walter Roberts; Kelly E Moore; Terril L Verplaetse; Yasmin Zakiniaeiz; Catherine Burke; Mackenzie R Peltier; Sherry A McKee Journal: J Stud Alcohol Drugs Date: 2021-09 Impact factor: 3.346
Authors: Elizabeth Charron; Akiko Okifuji; M Aryana Bryan; Sarah Reese; Jennifer L Brown; Andrew Ferguson; Udi E Ghitza; T Winhusen; Gerald Cochran Journal: J Pain Date: 2022-04-11 Impact factor: 5.383
Authors: Johanna Tanner; Tuija Teerijoki-Oksa; Hannu Kautiainen; Pekka Vartiainen; Eija Kalso; Heli Forssell Journal: Clin Exp Dent Res Date: 2022-03-28